GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Futura Medical PLC (OTCPK:FAMDF) » Definitions » Stock Based Compensation

FAMDF (Futura Medical) Stock Based Compensation : $2.57 Mil (TTM As of Dec. 2024)


View and export this data going back to 2007. Start your Free Trial

What is Futura Medical Stock Based Compensation?

Futura Medical's Stock Based Compensation for the six months ended in Dec. 2024 was $0.90 Mil. Its Stock Based Compensation for the trailing twelve months (TTM) ended in Dec. 2024 was $2.57 Mil.


Futura Medical Stock Based Compensation Historical Data

The historical data trend for Futura Medical's Stock Based Compensation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Futura Medical Stock Based Compensation Chart

Futura Medical Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Stock Based Compensation
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.20 0.24 0.82 3.44 2.56

Futura Medical Semi-Annual Data
Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Stock Based Compensation Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.66 0.81 2.63 1.66 0.90

Futura Medical Stock Based Compensation Calculation

Stock Based Compensation is a way corporations use stock options to reward employees. It provides executives and employees the opportunity to share in the growth of the company and, if structured properly, can align their interests with the interests of the company's shareholders and investors, without burning the company's cash on hand.

Stock Based Compensation for the trailing twelve months (TTM) ended in Dec. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was $2.57 Mil.


Futura Medical Stock Based Compensation Related Terms

Thank you for viewing the detailed overview of Futura Medical's Stock Based Compensation provided by GuruFocus.com. Please click on the following links to see related term pages.


Futura Medical Business Description

Traded in Other Exchanges
Address
40 Occam Road, Surrey Technology Centre, Guildford, Surrey, GBR, GU2 7YG
Futura Medical PLC is engaged in the development and commercialization of sexual health products. Its product Eroxon is a treatment for erectile dysfunction. Geographically, the company derives a majority of its revenue from the United Kingdom and the European Union.